Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Gene therapy for motor neuron disease

Adenoviral transfer of NT-3 and CNTF genes provides therapeutic benefit to mice with motor neuron disease (pages 429–436).

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Appel, S.H. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann. Neurol. 10, 499–505 (1981).

    Article  CAS  Google Scholar 

  2. Dittrich, F., Thoenen, H. & Sendtner, M. Ciliary neurotrophic factor: Pharmacokinetics and acute phase response. Ann. Neurol. 35, 151–163 (1994).

    Article  CAS  Google Scholar 

  3. Eriksson, N.P., Lindsay, R.M. & Aldskogius, H. BDNF and NT-3 rescue sensory but not motoneurones following axotomy in the neonate. Neuroreport 5, 1445–1448 (1994).

    CAS  Google Scholar 

  4. Vejsada, R., Sagot, Y. & Kato, A.C. Quantitative comparison of the transient rescue effects of neurotrophic factors on axotomized motoneurons in vivo. Eur. J. Neurosci. 7, 108–115 (1995).

    Article  CAS  Google Scholar 

  5. Carter, B.D., Zirrgiebel, U. & Barde, Y.-A. Differential regulation of p21ras activation in neurons by nerve growth factor and brain-derived neurotrophtc factor. J. Biol. Chem. 270, 21751–21757 (1995).

    Article  CAS  Google Scholar 

  6. Haase, G. et al. Gene therapy of a murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nature Med. 3, 429–436 (1997).

    Article  CAS  Google Scholar 

  7. Dittrich, F. et al. Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons. Exp. Neurol. 141, 225–239 (1996).

    Article  CAS  Google Scholar 

  8. Yan, Q. et al. Influences of neurotrophins on mammalian motoneurons in vivo. J. Neurobiol. 24, 1555–1577 (1993).

    Article  CAS  Google Scholar 

  9. Henderson, C.E. et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 363, 266–270 (1993).

    Article  CAS  Google Scholar 

  10. Griesbeck, O. et al. Expression of neurotrophins in skeletal muscle: Quantitative comparison and significance for motoneuron survival and maintenance of function. J. Neurosci. Res. 42, 21–33 (1995).

    Article  CAS  Google Scholar 

  11. Lohof, A.M., Ip, N.Y. & Poo, M. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 363, 350–353 (1993).

    Article  CAS  Google Scholar 

  12. Sagot, Y., Tan, S.A., Hammang, J.P., Aebischer, P. & Kato, A.C. GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J. Neurosci. 16, 2335–2341 (1996).

    Article  CAS  Google Scholar 

  13. Sendtner, M. et al. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358, 502–504 (1992).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sendtner, M. Gene therapy for motor neuron disease. Nat Med 3, 380–381 (1997). https://doi.org/10.1038/nm0497-380

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0497-380

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing